tradingkey.logo
tradingkey.logo
Buscar

Insulet Corp

PODD
Añadir a la lista de seguimiento
149.448USD
-8.902-5.62%
Horarios del mercado ETCotizaciones retrasadas 15 min
10.35BCap. mercado
34.67P/E TTM

Más Datos de Insulet Corp Compañía

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.

Información de Insulet Corp

Símbolo de cotizaciónPODD
Nombre de la empresaInsulet Corp
Fecha de salida a bolsaMay 15, 2007
Director ejecutivoMcevoy (Ashley)
Número de empleados3900
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 15
Dirección100 Nagog Park
CiudadACTON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01720-3440
Teléfono19786007000
Sitio Webhttps://www.omnipod.com
Símbolo de cotizaciónPODD
Fecha de salida a bolsaMay 15, 2007
Director ejecutivoMcevoy (Ashley)

Ejecutivos de Insulet Corp

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
27.70K
--
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
18.26K
+18.67%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
16.55K
-4.75%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
6.75K
+22.59%
Ms. Laetitia Cousin
Ms. Laetitia Cousin
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
5.36K
+35.90%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
5.24K
--
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Independent Director
Independent Director
4.22K
+8.71%
Mr. Prem Singh
Mr. Prem Singh
Senior Vice President - Global Operations
Senior Vice President - Global Operations
3.11K
-123.87%
Dr. Luciana Borio, M.D.
Dr. Luciana Borio, M.D.
Independent Director
Independent Director
2.31K
-33.69%
Mr. Timothy J. (Tim) Scannell
Mr. Timothy J. (Tim) Scannell
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
27.70K
--
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
18.26K
+18.67%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
16.55K
-4.75%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
6.75K
+22.59%
Ms. Laetitia Cousin
Ms. Laetitia Cousin
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
5.36K
+35.90%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
5.24K
--

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
Por negocioUSD
Nombre
Ganancia
Proporción
U.S.Omnipod
1.92B
70.89%
International Omnipod
754.30M
27.85%
Drug Delivery
34.10M
1.26%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
1.95B
72.15%
All Other
754.30M
27.85%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
U.S.Omnipod
1.92B
70.89%
International Omnipod
754.30M
27.85%
Drug Delivery
34.10M
1.26%

Estadísticas de accionistas

Actualizado: dom., 10 de may
Actualizado: dom., 10 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
8.18%
Vanguard Capital Management, LLC
6.61%
BlackRock Institutional Trust Company, N.A.
6.39%
Capital Research Global Investors
6.37%
Vanguard Portfolio Management, LLC
4.98%
Otro
67.48%
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
8.18%
Vanguard Capital Management, LLC
6.61%
BlackRock Institutional Trust Company, N.A.
6.39%
Capital Research Global Investors
6.37%
Vanguard Portfolio Management, LLC
4.98%
Otro
67.48%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
65.74%
Investment Advisor/Hedge Fund
26.60%
Hedge Fund
4.98%
Pension Fund
2.66%
Research Firm
2.51%
Sovereign Wealth Fund
1.60%
Bank and Trust
1.45%
Individual Investor
0.32%
Insurance Company
0.06%

Participación institucional

Actualizado: dom., 5 de abr
Actualizado: dom., 5 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
1624
73.18M
105.65%
-1.62M
2025Q4
1606
71.89M
102.19%
-3.38M
2025Q3
1546
72.07M
102.39%
-3.66M
2025Q2
1541
72.80M
103.47%
-3.81M
2025Q1
1569
72.82M
103.50%
-3.52M
2024Q4
1508
72.57M
103.34%
-4.94M
2024Q3
1436
73.14M
104.31%
-3.15M
2024Q2
1408
72.17M
103.04%
-3.02M
2024Q1
1350
71.60M
102.26%
-3.12M
2023Q4
1320
72.91M
104.42%
-1.52M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fidelity Management & Research Company LLC
5.66M
8.04%
-1.25M
-18.11%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
4.43M
6.29%
+254.00
+0.01%
Dec 31, 2025
Capital Research Global Investors
4.41M
6.26%
-140.10K
-3.08%
Dec 31, 2025
State Street Investment Management (US)
3.16M
4.48%
+65.32K
+2.11%
Dec 31, 2025
Baillie Gifford & Co.
2.05M
2.91%
-43.33K
-2.07%
Dec 31, 2025
Geode Capital Management, L.L.C.
2.01M
2.85%
+41.02K
+2.09%
Dec 31, 2025
American Century Investment Management, Inc.
1.58M
2.25%
+177.56K
+12.62%
Dec 31, 2025
ClearBridge Investments, LLC
1.39M
1.97%
-79.75K
-5.44%
Dec 31, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Langar Global HealthTech ETF
7.26%
Innovator IBD Breakout Opportunities ETF
4.88%
Global X HealthTech ETF
4.76%
Goldman Sachs Future Health Care Equity ETF
4.2%
First Trust Nasdaq Lux Digi Health Solutions ETF
3.7%
iShares Health Innovation Active ETF
3%
Congress SMid Growth ETF
2.82%
iShares U.S. Medical Devices ETF
2.62%
FT Raymond James Multicap Growth Equity ETF
2.3%
Acruence Active Hedge US Equity ETF
2.27%
Ver más
Langar Global HealthTech ETF
Proporción7.26%
Innovator IBD Breakout Opportunities ETF
Proporción4.88%
Global X HealthTech ETF
Proporción4.76%
Goldman Sachs Future Health Care Equity ETF
Proporción4.2%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción3.7%
iShares Health Innovation Active ETF
Proporción3%
Congress SMid Growth ETF
Proporción2.82%
iShares U.S. Medical Devices ETF
Proporción2.62%
FT Raymond James Multicap Growth Equity ETF
Proporción2.3%
Acruence Active Hedge US Equity ETF
Proporción2.27%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI